Article By:
Bret Jensen
Saturday, June 11, 2016 1:31 PM EDT
Don’t let the resurgence in M&A in the biotech sector pass you by. Bret Jensen shares his top five picks for likely acquisition targets in biotech.
In this article: AGN, AZN, PFE, SGYP, SNY, VRX, ACAD, ANAC, MDVN, PGNX, XNPT, BIIB, TEVA, ABBV, CPXX, IONS
